United States · Series A startup

Who invested in Rapafusyn Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$16Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $16MSept 2025
Investors
1
See who backed them

The rounds

  1. Sept 2025
    Series A$16M

    Source recorded

Founders and team

From Rapafusyn Pharmaceuticals's own website: 2 on the team.

  • Alex RabbyHead of Platform
  • Haolin SungDirector

Everyone who backed them

3E BioventuresVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rapafusyn Pharmaceuticals

Who invested in Rapafusyn Pharmaceuticals?

Rapafusyn Pharmaceuticals's investors include 3E Bioventures.

How much has Rapafusyn Pharmaceuticals raised?

Rapafusyn Pharmaceuticals has raised $16M across 1 round since 2025.

When did Rapafusyn Pharmaceuticals last raise?

Rapafusyn Pharmaceuticals's most recent round was a Series A of $16M in Sept 2025.

What was Rapafusyn Pharmaceuticals's biggest round?

Its most recent round, $16M in Sept 2025, is also its largest on record.

Who backed Rapafusyn Pharmaceuticals first?

Rapafusyn Pharmaceuticals's first round on record, in Sept 2025, was backed by 3E Bioventures.

What stage is Rapafusyn Pharmaceuticals at?

Rapafusyn Pharmaceuticals's latest named round is a Series A, in Sept 2025.

Where is Rapafusyn Pharmaceuticals based?

Rapafusyn Pharmaceuticals is based in the United States.

Companies like Rapafusyn Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.